The massive credit loss provisions and supplier impairments suggest serious collectability and working capital issues. Monitor subsequent filings for further deterioration in accounts receivable and advances to suppliers, as well as any going concern disclosures in the next annual report.
Price Chart
Executive Summary
Bon Natural Life reported a net loss of $9.2M for H1 2026 vs net income of $169K in H1 2025, driven by massive credit loss provisions ($5.7M) and supplier impairment charges ($1.9M). Revenue was essentially flat (+1.9%) as a 60% decline in the core fragrance compound segment offset growth in health supplements and bioactive ingredients. The company swung from operating income of $284K to an operating loss of $8.6M.
Key Facts
- Net loss attributable to Bon Natural Life of $9,201,131 for H1 2026 vs net income of $169,227 in H1 2025, a decrease of 5537.2%
- Revenue essentially flat at $8,097,810, up only 1.9% from $7,949,845
- Operating loss of $8,575,392 vs operating income of $284,050 in prior year period
- Provision for credit losses of $5,656,888 (69.9% of revenue) including $2,566,939 against accounts receivable and $3,089,949 against other receivables
- Impairment losses on advances to suppliers of $1,920,508 (23.7% of revenue)
- Fragrance compound revenue declined 60.4% to $2,240,374 from $5,663,910
- Basic and diluted loss per share of $1.51 vs basic EPS of $0.56 and diluted EPS of $0.50 in prior year
- Cash and restricted cash of $9,181,655 as of March 31, 2026
- Retained earnings dropped from $16,630,831 to $7,429,700
Financial Impact
Net loss of $9.2M vs prior year net income of $169K; operating loss of $8.6M vs prior year operating income of $284K; credit loss provisions and supplier impairments totaling $7.6M
Risk Factors
- Continued decline in core fragrance compound segment (-60.4% revenue) with no recovery timeline
- Credit quality deterioration with $5.7M in provisions against receivables
- Supplier advance impairment of $1.9M indicates supply chain disruption
- Retained earnings cut by more than half, reducing equity cushion
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-043944 |
| Exhibit: ex99-1.htm | 0001493152-26-043944 |
| Document: 0001493152-26-043944-index-headers.html | 0001493152-26-043944 |
| Document: 0001493152-26-043944-index.html | 0001493152-26-043944 |
| Document: 0001493152-26-043944.txt | 0001493152-26-043944 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 6-K | $1.21 $1.15 | ▲ +5.04% | ▲ +4.62% | $1.17 (+3.31%) |
Apr 10, 2026 28w ago | 3 | $1.29 $1.21 | ▼ −6.20% | ▼ −13.93% | $1.17 (−9.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers